S2
SI Table of Contents:  S2-S5 Tables and figures referenced in the main text S6 General Considerations S7 Cell Culture and Live Cell Imaging S8 Preparation of Pt-XL crosslinker S9-S12 Preparation of DOX-MM S13-S14 Preparation of CPT-MM S15 General Procedure for BASP Synthesis S16-S35 Spectra Data S36 References
Tables and figures referenced in the main text: Figure S1 . GPC traces of drug-loaded BASPs and their parent bottlebrush polymers (the latter are the brush polymers obtained after graft-through MM polymerization and before addition of platinum crosslinker). DP = average degree of polymerization. Table S1 . Characterization data for multi-drug-loaded BASPs. Note: See Figure S29 for NMR integration data, which provides estimated molar ratio of CPT and DOX. a weight-average molecular weight (M w ) from GPC. Note: M w values were obtained by comparison to PEG standards. b dispersity index from GPC (M w /M n ). c theoretical weight fraction of cisplatin based on brush-first ROMP stoichiometry. d weight fraction of cisplatin as determined by inductively-coupled plasma mass spectrometry (ICP-MS) e theoretical weight fraction of DOX based on brush-first ROMP stoichiometry. f weight fraction of DOX as determined by UV-Vis. g theoretical weight fraction of CPT based on brush-first ROMP stoichiometry. h weight fraction of CPT as determined by UV-Vis. S3 i ppm of residual Cu in BASP after dialysis against water for 1 h (external solution exchanged after 30 min) and acetone for 1 h (external solution exchanged after 30 min) as determined by ICP-MS. j ppm of residual Ru in BASP after dialysis against water for 1 h (external solution exchanged after 30 min) and acetone for 1 h (external solution exchanged after 30 min) as determined by ICP-MS. 
General Considerations
All reagents and solvents were purchased from Aldrich or VWR and used as supplied unless otherwise noted. Platinum complexes a3 2 , ruthenium metathesis catalyst (cat) 3 , N-(glycine)-cis-5-norbornene-exo-dicarboximide a1 4 , PEG-MM 1 and PEG-Alkyne-MM 5 were prepared according to literature procedures. Degassed dichloromethane (DCM) and tetrahydrofuran (THF) were passed through solvent purification columns prior to use.
Liquid chromatography-mass spectrometry (LC/MS) and preparative HPLC were performed on an Agilent 1260 LC system equipped with a Zorbax SB-C18 rapid resolution HT column and a Zorbax SB-C18 semi-preparative column. Solvent gradients consisted of mixtures of nano-pure water with 0.1% acetic acid (AcOH) and HPLC-grade acetonitrile. Mass spectra were obtained using an Agilent 6130 single quadrupole mass spectrometer.
Dynamic light scattering (DLS) measurements were made at room temperature using a Wyatt Technology DynaPro Titan DLS instrument. Samples were dissolved in nanopure water at a concentration of ~1 mg / mL. A fresh, clean, polystyrene cuvette was washed with compressed air to remove dust. The sample solution was passed through a 0.4 µm Teflon syringe filter directly into the cuvette; the cuvette was capped and placed in the DLS instrument for particle sizing. At least 3 measurements were made per sample and average hydrodynamic diameters were calculated by fitting the DLS correlation function using the CONTIN routine (Dynamics V6 software package from DynaPro Wyatt Technology) 1 H nuclear magnetic resonance ( 1 H-NMR), 13 C nuclear magnetic resonance ( 13 C-NMR) and 195 Pt nuclear magnetic resonance ( 195 Pt-NMR) spectra were recorded on Bruker AVANCE-400 NMR spectrometer, Mercury 300 MHz spectrometer, or INOVA 500 MHz spectrometer. Chemical shifts are reported in ppm and referenced to the CHCl 3 singlet at 7.26 ppm, DMSO at 2.50 ppm or CH 2 Cl 2 at 5.30 ppm. 13 C-NMR spectra were referenced to the center line of the CDCl 3 triplet at 77.0 ppm, DMSO septet at 39.5 ppm or CD 2 Cl 2 quintet at 54.0 ppm. 195 Pt-NMR spectra were referenced using an external K 2 PtCl 6 in D 2 O at -1628 ppm. Chemical shifts are expressed in parts per million (ppm), and splitting patterns are designated as s (singlet), d (doublet), t (triplet), m (multiplet) and br (broad). Coupling constants J are reported in Hertz (Hz). MestReNova NMR 7.0.1 software was used to analyze the NMR spectra.
Gel permeation chromatography (GPC) measurements were performed on an Agilent 1260 LC system with two Shodex KD-806M GPC columns in series at 60 °C and a flow rate of 1 mL / min. N,N-Dimethylformamide (DMF) with 0.2M LiBr was used as the eluent. A T-rEX refractive index detector (Wyatt) and a DAWN EOS 18-angle laser light scattering (MALLS) detector (Wyatt) were used for polymer analysis.
High-resolution mass spectrometry (HRMS) was obtained using a Bruker Daltonics APEXIV 4.7 Tesla Fourier Transform Ion Cyclotron Resonance Mass Spectrometer (FT-ICR-MS). TEM images were obtained at the MIT Center for Materials Science and Engineering on a JEOL 2011 High Contrast Digital TEM. The samples were prepared as follows: 5.0 µL of a 0.050 mg/mL solution of 20xL (or 15 xL) BASP polymer was deposited via pipet on top of a carbon film-coated 200-mesh copper grid (purchased from Electron Microscopy Sciences) placed on a piece of parafilm carbon-coated side up. The sample was allowed to dry at room temperature and then ready for TEM imaging. For positive stain, the sample was further placed carbon-coated side up on top of a LC/MS vial covered with foil. The LC/MS vial was placed inside a 20mL scintillation vial and to the scintillation vial was added ~0.30 mL of a 0.5 wt% RuO 4 aqueous solution; the scintillation vial was capped and allowed to stand for 30 min. For negative stain, the sample was further stained with 2 wt% uranyl acetate aqueous solution. After 1 min, the excess staining solution was quickly wicked away by a piece of filter paper and the samples were left to dry under ambient conditions overnight.
Photolysis experiments were performed using a Multiple Ray Lamp (UVP) fitted with an 8 W, longwave, filtered blacklight bulb (365 nm).
Cell Culture and Live Cell Imaging
OVCAR3 cells (ATCC) were maintained in RPMI-1640 media supplemented with 0.01 mg/mL recombinant human insulin (Gibco), 20% fetal bovine serum, and penicillin/streptomycin in a 5% CO 2 humidified atmosphere (37 °C). Assays and imaging were performed on cells passaged 12-24 h prior. Dose-response curves were fit using a four-parameter logistic regression analysis and statistical significance was assessed by two-tailed t-test (95% CI) for *P<0.01, **P<0.05, and ***P<0.001. BASP drug conjugates were reconstituted in ultrapure water (18 MΩ) containing 5% D-glucose and stored at 4 °C in dark prior to use. Viability was assessed by CellTiter-Glo assay (Promega) following 72 h total incubation time with MDLP-spiked OPTIMEM medium. 90 min after nanoparticle introduction, assay plates were exposed for 10 min with a portable UV lamp (UVP Inc; 2.0±0.3 mW/cm 2 @ 365 nm) and returned to the incubator. Confocal fluorescence measurements were performed following incubation with 133 uM acridine orange (Sigma) and 66.6 µg/mL BASP drug conjugate in complete basal medium. After 30 min, cell growth media were replaced with 10 mM HEPES (pH 7.4) containing 10% FBS and imaging (1 exposure min -1 ) was performed using the 405, 488, and/or 561 nm laser lines of a Nikon 1AR ultra-fast spectral scanning confocal microscope (λ em : 525/50, 595/50 nm) fitted with a temperature-controlled environment chamber and 60x oil immersion objective.
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Synthetic Procedures
Synthesis of Pt-XL Norbornene anhydride a2. N-(glycine)-cis-5-norbornene-exo-dicarboximide (760 mg, 3.4 mmol) and N,N'-Dicyclohexylcarbodiimide (DCC) (360 mg, 1.7 mmol) were dissolved in anhydrous DCM (60 mL) and the resulting solution was stirred at room temperature overnight. The reaction mixture was then filtered and the filtrate was concentrated via rotary evaporator to give 3 as white solid (583 mg, 80% yield). 1 
Synthesis of DOX-MM
Synthesis of 5-(3-chloropropoxy)-2-nitrobenzaldehyde b2. 6 1-bromo-3-chloropropane (0.650 mL, 0.00658 moles) was added to a solution of 5-hydroxy-2-nitrobenzaldehyde (1.0g, 0.00598 moles) and potassium carbonate (1.66g, 0.0120 moles) in anhydrous DMF (6 mL). The solution was stirred at 40 °C for 24 hours. The reaction was diluted with ethyl acetate (75 mL) and washed with saturated sodium bicarbonate solution (75 mL), water (75 mL), and brine (75 mL). The organic layer was dried with anhydrous magnesium sulfate, which was removed by filtration. The solution was concentrated and silica gel chromatography was performed using a gradient of 100% hexanes to 50% ethyl acetate in hexanes. The fractions containing product were collected, then solvent was removed by rotary evaporation, and dried overnight to yield 5-(3-chloropropoxy)-2-nitrobenzaldehyde as a bright-green yellow solid (yield 87%*). 1 Sodium borohydride (133 mg, 0.00351 moles) was added to 5-(3-chloropropoxy)-2-nitrobenzaldehyde (570 mg, 0.00234 moles) in anhydrous methanol (12 mL) at 0 °C under nitrogen. The reaction was stirred for 1.5 hours, then concentrated with a rotary evaporator. The mixture was diluted with ethyl acetate (75 mL), and washed with 30mL each of saturated sodium bicarbonate solution, water, and brine. The organic layer was dried with anhydrous magnesium sulfate, which was removed by filtration. The solution was concentrated and silica gel chromatography was performed using a gradient of 100% hexanes to 60% ethyl acetate in hexanes. The fractions containing product were collected, then solvent was removed by rotary evaporation, and dried overnight to yield (5-S11 (3-chloropropoxy)-2-nitrophenyl)methanol as a pale yellow solid (yield 69%*). 1 H NMR (400 MHz, CD 2 Cl 2 ) δ 8.16 (d, J = 9.1 Hz, 1H), 7.27 (d, J = 2.7 Hz, 1H), 6.92 (dd, J = 9.1, 2.8 Hz, 1H), 4.98 (s, 2H), 4.24 (t, J = 5.9 Hz, 2H), 3.77 (t, J = 6.3 Hz, 2H), 2.28 (p**, J = 6.1 Hz, 2H). 13 *Observed extra NMR peaks, but does not interfere with next step: 1H NMR (400 MHz, Methylene Chloride-d2) δ 3.63 (t, J = 6.3 Hz, 0.14H), 2.39-2.31 (m, 0.24H) ** pseudo pentet Synthesis of (5-(3-azidopropoxy)-2-nitrophenyl)methanol b4. DMF (7.5 mL) was added to (5-(3-chloropropoxy)-2-nitrophenyl)methanol (635 mg, 0.00258 moles) and sodium azide (252 mg, 0.00387 moles) in a flask, which was heated to 70 °C and stirred overnight. The reaction was diluted in ethyl acetate (100 mL), and washed twice with water (75 mL each) and once with brine (75 mL). The organic layer was dried with anhydrous magnesium sulfate, which was filtered out. The solution was concentrated on a rotary evaporator and dried on vacuum overnight to yield (5-(3-azidopropoxy)-2-nitrophenyl)methanol as a yellow solid (yield 88%). 1 5 ) A solution of (5-(3-azidopropoxy)-2-nitrophenyl)methanol (250 mg, 0.00099 moles) and triethylamine (0.21 mL, 0.0015 moles) in tetrahydrofuran (5 mL) was added dropwise to a flask of 4-nitrophenyl chloroformate (423mg, 0.0021 moles) in tetrahydrofuran (15 mL) at 0 °C under nitrogen. The ice-bath was removed and the reaction was left to stir for one hour. The mixture was concentrated on a rotary evaporator and purified by silica gel chromatography from 100% hexanes to 100% ethyl acetate. The fractions containing product was concentrated on a rotary evaporator and dried on vacuum overnight to yield b5 as a yellow solid (yield 65%*). 1 3 . Doxorubicin hydrochloride (70.6 mg, 0.000122 moles) was dissolved DMF (1.5mL), followed by addition of DIPEA (0.021 mL, 0.000122 moles) and b5 (48 mg, 0.000116 moles). The solution was stirred at room temperature overnight, then diluted in ethyl acetate (75 mL), washed twice with water (50 mL each) and brine (50 mL). The organic layer was dried with anhydrous magnesium sulfate, which was removed by filtration. The solution was concentrated and silica gel chromatography was performed using a gradient of 100% dichloromethane to 10% methanol in dichloromethane. The fractions containing product were collected, then solvent was removed by rotary evaporation, and dried overnight to yield DOX-N 3 as a red solid (yield 92%*). 1 3 (49 mg, 0.060 mmol) and PEG-Alkyne-MM (300 mg, 0.060 mmol) in 10 ml DCM, was added CuOAc (0.6 mg, 4.8 µmmol) under N 2 . The reaction was allowed to stir at room temperature and monitored by LC-MS until the complete consumption of PEG-Alkyne-MM. Then the solvent was removed under vacuum and the residue was purified by HPLC diluting with water (containing 0.1% acetic acid) and acetonitrile. The desired DOX-MM was obtained as light yellow powder (174 mg, 70% yield). 1 H NMR and MALDI were provided at the end of the SI.
Synthesis of CPT-MM Synthesis of c2
The THF (35 mL) solution of the silyl ether c1 7 (3.5 g, 10.5 mmol) and TBAF (5.5 g, 21 mmol) was allowed to stir under N 2 at room temperature overnight. Then the reaction mixture was concentrated under vacuum and the residue was purified by flash chromatography diluting with hexanes and ethyl acetate to give c2 (colorless oil, 2.3 g, 99% yield). The characterization was compared with previously reported data. 8 
Synthesis of c3
To a solution of c2 (1.1 g, 5.0 mmol) in acetone (55 mL) at 0 ˚C, was added a solution of CrO 3 (1.5 g, 15 mmol) in 1.5 M H 2 SO 4 in water (31 mL) dropwise by an additional funnel. After addition, the reaction was allowed to stir at room temperature overnight. The reaction was then quenched by addition of isopropanol (30 mL) and concentrated under vacuum. The aqueous residue was extracted by DCM (50 mL × 4). The organic layer was combined, dried over Na 2 SO 4 and concentrated under vacuum. The product was purified by silica flash chromatography diluting with hexanes and ethyl acetate to give colorless oil (1.2 g, 99% yield). The characterization was compared with previously reported data. 9 Synthesis of CPT-N 3 The mixture of CPT (64 mg, 0.18 mmol), c3 (86 mg, 0.37 mmol), N-(3dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (EDC·HCl, 71 mg, 0.37 mmol) and 4-dimethylaminopyridine (DMAP, 45 mg, 0.37 mmol) in DCM (10 mL) was allowed to stir under N 2 at room temperature overnight. The reaction was then concentrated under vacuum and the product was purified by flash chromatography diluting with 5% MeOH in DCM to give yellow solid (81 mg, 78% yield). 1 Figure S11 . 13 Table S1 .
